Back
SpringWorks Therapeutics Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
32
SWTX
SpringWorks Therapeutics
Last Price:
$35.66
Seasonality Move:
4.38%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.36 | Sell |
| 20-day SMA: | 39.76 | Sell |
| 50-day SMA: | 35.2 | Buy |
| 200-day SMA: | 39.14 | Sell |
| 8-day EMA: | 37.2 | Sell |
| 20-day EMA: | 38.05 | Sell |
| 50-day EMA: | 36.86 | Sell |
| 200-day EMA: | 36.89 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 40.04 | Sell |
| Chaikin Money Flow: | 622558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.6 - 41.64) | Sell |
| Bollinger Bands (100): | (31.74 - 39.68) | Sell |
SpringWorks Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 35.63 while SWTX 8-day simple moving average is 37.36, which is a Sell signal.
-
The stock price of SWTX is 35.63 while SpringWorks Therapeutics 20-day SMA is 39.76, which makes it a Sell.
-
SpringWorks Therapeutics 50-day simple moving average is 35.20 while SWTX share price is 35.63, making it a Buy technically.
-
SWTX stock price is 35.63 and SpringWorks Therapeutics 200-day simple moving average is 39.14, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
32
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $35.63. The Score for SWTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.7B
Price in USD:
35.63
Share Volume:
1.1M
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
28.21
Sell
32
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 35.63 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 35.63 while SWTX 8-day exponential moving average is 37.20, which is a Sell signal.
-
The stock price of SWTX is 35.63 while SpringWorks Therapeutics 20-day EMA is 38.05, which makes it a Sell.
-
SpringWorks Therapeutics 50-day exponential moving average is 36.86 while SWTX share price is 35.63, making it a Sell technically.
-
SWTX stock price is 35.63 and SpringWorks Therapeutics 200-day simple moving average is 36.89, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.22 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting SpringWorks Therapeutics is a Buy
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 40.04, which suggest SpringWorks Therapeutics is oversold
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (36.6 - 41.64), which suggest SpringWorks Therapeutics is a Sell
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (31.74 - 39.68), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.